Biomet Offers $280M For Johnson & Johnson Trauma Biz

Law360, New York (April 3, 2012, 2:35 PM EDT) -- Medical device maker Biomet Inc. offered Tuesday to scoop up Johnson & Johnson's global trauma business for $280 million, a divestment that could help the health care giant assuage European Union antitrust regulators' concerns over J&J's proposed $21.3 billion merger with orthopedic device maker Synthes Inc.

The binding offer, which expires June 1, proposes an all-cash deal to buy up DePuy Orthopaedics Inc., a worldwide business based in Massachusetts and Indiana that, like Biomet, makes devices for hip, knee and trauma surgeries, as well as bone...
To view the full article, register now.